Evidence map›Paper›PMID 33608270›Full record

ArticleScience advances2021

PKA Cα subunit mutation triggers caspase-dependent RIIβ subunit degradation via Ser

Isabel Weigand, Cristina L Ronchi, Jens T Vanselow, Kerstin Bathon, Kerstin Lenz, Sabine Herterich, Andreas Schlosser, Matthias Kroiss, Martin Fassnacht, Davide Calebiro and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00669266 (Investigation of the Tumorigenesis of Adrenal Tumors and Evaluation of New Therapeutic Options - Untersuchungen Zur Tumorgenese Von Nebennierentumoren Und Evaluation Neuer Therapieoptionen), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00669266 recruitingnot on this map

Investigation of the Tumorigenesis of Adrenal Tumors and Evaluation of New Therapeutic Options - Untersuchungen Zur Tumorgenese Von Nebennierentumoren Und Evaluation Neuer Therapieoptionen

TypeobservationalSponsorUniversity of WuerzburgRan2002 to 2032Enrolled500ConditionsAdrenal Tumors, Adrenocortical Carcinoma, Cushing Syndrome, Conn Syndrome
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Characterisation of aEndocrine oncology (Bristol, England) · 2025
    Article
  3. The molecular genetics of adrenal cushing.Hormones (Athens, Greece) · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. The Tails of Protein Kinase A.Molecular pharmacology · 2022
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Isabel WeigandDivision of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Würzburg, 97080 Würzburg, Germany.ORCID 0000-0001-5873-8567
Cristina L RonchiDivision of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Würzburg, 97080 Würzburg, Germany.
Jens T VanselowRudolf-Virchow-Center for Integrative and Translational Bioimaging, University of Würzburg, 97080 Würzburg, Germany.ORCID 0000-0001-8900-8209
Kerstin BathonInstitute of Pharmacology and Toxicology and Bio-Imaging Center, University of Würzburg, 97080 Würzburg, Germany.
Kerstin LenzDivision of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Würzburg, 97080 Würzburg, Germany.
Sabine HerterichCentral Laboratory, University Hospital Würzburg, 97080 Würzburg, Germany.
Andreas SchlosserRudolf-Virchow-Center for Integrative and Translational Bioimaging, University of Würzburg, 97080 Würzburg, Germany.ORCID 0000-0003-0612-9932
Matthias KroissDivision of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Würzburg, 97080 Würzburg, Germany.ORCID 0000-0002-7628-3161
Martin FassnachtDivision of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Würzburg, 97080 Würzburg, Germany. fassnacht_m@ukw.de sbiera_s@ukw.de.ORCID 0000-0001-6170-6398
Davide CalebiroInstitute of Metabolism and System Research, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.ORCID 0000-0002-3811-1553
Silviu SbieraDivision of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Würzburg, 97080 Würzburg, Germany. fassnacht_m@ukw.de sbiera_s@ukw.de.ORCID 0000-0002-6271-5533
University of Würzburg · DEUniversitätsklinikum Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in the

Identifiers

PMID33608270
PMCPMC7895437
OpenAlexW3131255998

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.